Stocksigma LogoStocksigma Logo

Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Transition

Tavexia Lifecare's board authorized evaluating and negotiating the acquisition of up to a 60% equity stake in Meyonex Pharmaceuticals Ltd, which has a

Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Transition

Sattva Sukun Lifecare Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 1:00 am

Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Transition Tavexia Lifecare's board authorized evaluating and negotiating the acquisition of up to a 60% equity stake in Meyonex Pharmaceuticals Ltd, which has a paid-up capital of Rs 13.99 cr. Additionally, the board accepted the resignation of statutory auditor M/s SSRV & Associates effective 7th Sep'26 and approved the appointment of M/s DEVAM & Associates LLP for a five-year term (FY27 to FY31), subject to shareholder approval. The board also approved the reappointment of Independent Director Khushboo Vasudev for a second five-year term.

Original exchange filing (PDF)

More announcements from Sattva Sukun Lifecare Ltd

All Sattva Sukun Lifecare Ltd announcements